A phase I and pharmacokinetic (PK) study of BIBW 2992, an oral irreversible dual EGFR/HER2 inhibitor

  1. Lookup NU author(s)
  2. Professor Ruth Plummer
  3. Rebecca Perrett
  4. Professor Alan Calvert
Author(s)Plummer ER, Vida L, Perrett R, Spicer J, Stopfer P, Shahidi M, Temple G, Futreal A, Calvert H, deBono J
Editor(s)
Publication type Conference Proceedings (inc. Abstract)
Conference Name14th European Cancer Conference (ECCO 14)
Conference LocationBarcelona, Spain
Year of Conference2007
Legacy Date23-27 September 2007
Volume5
Pages108-108
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherPergamon
URLhttp:/dx.doi.org/10.1016/S1359-6349(07)70502-5
DOI10.1016/S1359-6349(07)70502-5
NotesAbstract no. 703